Delivery Order SPE2DB24D2205-SPE2DB24FDTYU
Award Date
5/10/24
Potential Completion Date
5/13/24
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,201.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Insulin Degludec Pen (U-100) 3ML, a specialty medication used for diabetes management. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of insulin degludec pens (U-200, 3 mL). The contract has a ceiling value of $4,417.19 and a completion date of January 2, 2025. It is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $1,710.72 firm fixed price contract is for the supply of insulin degludec pens (U-100, 3 mL) to support military treatment facilities and federal healthcare programs. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of insulin degludec pens (U-100), 3 mL, with a ceiling value of $4,188.48 and a completion date of February 5, 2025. The contract is a Firm Fixed Price arrangement and is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order valued at $1,313.56 for the supply of Insulin Degludec Pen (U-200) 3ML. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, that enables the agency to efficiently procure a comprehensive range of pharmaceutical and medical supplies...
The Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $3,930.60 firm fixed price delivery order contract for the supply of insulin degludec pens (U-200, 3ML). This delivery order is placed under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen Drug Corp to deliver...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,289.17 firm fixed-price delivery order is for the supply of Insulin Degludec Pen (U-100) 3mL, a critical medical product used in the management of diabetes. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,190.14 firm fixed-price contract is for the supply of Insulin Degludec Pen (U-200) 3ML, a specialty medication used for diabetes management. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves...
The U.S. Department of Defense (DOD) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4,564,184,917 units of Insulin Degludec Pens (U-200) 3ML. The contract, valued at $4,137.57, has an ultimate completion date of April 8, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is issued under a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by the...
This federal contract award, with ID SPE2DB24D2205|SPE2DB25FDYCH, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,201.50 Firm Fixed Price delivery order is for the supply of Insulin Degludec Pens (U-100), 3ML. The contract has an ultimate completion date of February 10, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...